Fatal pulmonary tumor thrombotic microangiopathy caused by undiagnosed metastatic gastric adenocarcinoma

Por Endicott-Yazdani, Tiana, Ghazi, Alexia, Armstrong, Danielle, Guileyardo, Joseph, Schuller, Dan
Publicado no Proc (Bayl Univ Med Cent) (2015)

Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients

Por Wakefield, Amanda, Pignata, Antonella, Ghazi, Alexia, Ashoori, Aidin, Hegde, Meenakshi, Landi, Daniel, Gray, Tara, Scheurer, Michael E., Chintagumpala, Murali, Adesina, Adekunle, Gottschalk, Stephen, Hicks, John, Powell, Suzanne Z., Ahmed, Nabil
Publicado no J Neurooncol (2015)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy

Por Grada, Zakaria, Hegde, Meenakshi, Byrd, Tiara, Shaffer, Donald R, Ghazi, Alexia, Brawley, Vita S, Corder, Amanda, Schönfeld, Kurt, Koch, Joachim, Dotti, Gianpietro, Heslop, Helen E, Gottschalk, Stephen, Wels, Winfried S, Baker, Matthew L, Ahmed, Nabil
Publicado em 2013

Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma

Por Ghazi, Alexia, Ashoori, Aidin, Hanley, Patrick, Salsman, Vita S, Shaffer, Donald R, Kew, Yvonne, Powell, Suzanne Z, Grossman, Robert, Grada, Zakaria, Scheurer, Michael E, Hegde, Meenakshi, Leen, Ann M, Bollard, Catherine M, Rooney, Cliona M, Heslop, Helen E, Gottschalk, Stephen, Ahmed, Nabil
Publicado em 2012

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.

Por Ahmed, Nabil, Brawley, Vita, Hegde, Meenakshi, Bielamowicz, Kevin, Wakefield, Amanda, Ghazi, Alexia, Ashoori, Aidin, Diouf, Oumar, Gerken, Claudia, Landi, Daniel, Kalra, Mamta, Yi, Zhongzhen, Rooney, Cliona, Dotti, Gianpietro, Gee, Adrian, Heslop, Helen, Gottschalk, Stephen, Powell, Suzanne, Grossman, Robert, Wels, Winfried, Kew, Yzonne, Baskin, David, Zhang, Jonathan, New, Pamela, Hicks, John
Publicado no J Immunother Cancer (2015)

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Por Ahmed, Nabil, Brawley, Vita S., Hegde, Meenakshi, Robertson, Catherine, Ghazi, Alexia, Gerken, Claudia, Liu, Enli, Dakhova, Olga, Ashoori, Aidin, Corder, Amanda, Gray, Tara, Wu, Meng-Fen, Liu, Hao, Hicks, John, Rainusso, Nino, Dotti, Gianpietro, Mei, Zhuyong, Grilley, Bambi, Gee, Adrian, Rooney, Cliona M., Brenner, Malcolm K., Heslop, Helen E., Wels, Winfried S., Wang, Lisa L., Anderson, Peter, Gottschalk, Stephen
Publicado no J Clin Oncol (2015)